Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 16718699.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recessive mutations in ALS2 (juvenile amyotrophic lateral sclerosis) are causative for early-onset upper motor neuron diseases, including infantile ascending hereditary spastic paralysis (IAHSP). The goal of this study is to identify novel disease-causing ALS2 mutations. Mutations in ALS2 were screened by direct sequencing of complementary DNA obtained from patients' lymphoblasts. We report a novel ALS2 missense mutation in patients affected by IAHSP. This homozygous G669A mutation in exon 4 is predicted to result in a tyrosine substitution at cysteine 156 of the RCC1 (regulator of chromatin condensation)-like domain, encoding a putative guanine exchange factor for Ran guanosine triphosphatase, leading to a loss of ALS2 function due to instability of mutant protein. These results highlight the important role of the RCC1-like domain in ALS2 stability and function that is essential for upper motor neuron maintenance.
Medical subject headings
- Guanine Nucleotide Exchange Factors
- Mutation, Missense
- Spastic Paraplegia, Hereditary